YVETTE NARANJO: Open Payments
NPI 1255806170 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,230 in 119 payments from 20 companies in 2025. Trend: 2023 $2,613 · 2024 $2,106 · 2025 $3,230
Food & beverage: $3,230
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $586 |
| GlaxoSmithKline, LLC. | 30 | $534 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $459 |
| Verona Pharma, Inc. | 17 | $378 |
| Insmed, Inc. | 14 | $357 |
| Regeneron Healthcare Solutions, Inc. | 13 | $232 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $124 |
| Merck Sharp & Dohme LLC | 3 | $96 |
| Baxter Healthcare | 4 | $92 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
Products named: NUCALA, Ohtuvayre, Arikayce, OFEV, DUPIXENT, FASENRA, TEZSPIRE, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
